Figure S3 from Therapeutic Implications of Detecting MAPK-Activating Alterations in Cutaneous and Unknown Primary Melanomas

Autor: Nikolaus Schultz, Jedd D. Wolchok, Katherine S. Panageas, David B. Solit, Klaus J. Busam, Paul B. Chapman, Neal Rosen, Daniel G. Coit, Mary Susan Brady, Christopher A. Barker, Charlotte E. Ariyan, Suresh Nair, Parisa Momtaz, Michael A. Postow, Allison Betof Warner, Margaret K. Callahan, Penina Krieger, Jorge A. Rojas Zamalloa, Havish S. Kantheti, Francisco Sanchez-Vega, Arshi Arora, Walid K. Chatila, Alexander N. Shoushtari
Rok vydání: 2023
Popis: Kaplan-Meier curves for overall survival. (A) PD-1 monotherapy by driver class. (B) nivolumab plus ipilimumab by driver class. (C) PD-1 monotherapy by primary site of melanoma. (D) nivolumab plus ipilimumab by primary site of melanoma.
Databáze: OpenAIRE